A small molecule ACT004 targets four-and-a-half LIM domain protein 1 to disrupt TGF-β/Smad signaling and promote FHL1 degradation in renal fibrosis.
- DOI
- 10.1016/j.phrs.2026.109640
- Published
- 2026 Sep 24
- Container
- Pharmacological research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.phrs.2026.109640,
title = {A small molecule ACT004 targets four-and-a-half LIM domain protein 1 to disrupt TGF-β/Smad signaling and promote FHL1 degradation in renal fibrosis.},
author = {He X and Peng F and Wang H and Yang J and Long Y and Lu D and Zhao L and Huang Q and Li Q and Ma N and Chen X and Long H},
year = {2026},
journal = {Pharmacological research},
doi = {10.1016/j.phrs.2026.109640},
url = {https://doi.org/10.1016/j.phrs.2026.109640}
}RIS
TY - JOUR TI - A small molecule ACT004 targets four-and-a-half LIM domain protein 1 to disrupt TGF-β/Smad signaling and promote FHL1 degradation in renal fibrosis. AU - He X AU - Peng F AU - Wang H AU - Yang J AU - Long Y AU - Lu D AU - Zhao L AU - Huang Q AU - Li Q AU - Ma N AU - Chen X AU - Long H PY - 2026 JO - Pharmacological research DO - 10.1016/j.phrs.2026.109640 UR - https://doi.org/10.1016/j.phrs.2026.109640 ER -
APA
X, H., F, P., H, W., J, Y., Y, L., D, L., L, Z., Q, H., Q, L., N, M., X, C., & H, L. (2026). A small molecule ACT004 targets four-and-a-half LIM domain protein 1 to disrupt TGF-β/Smad signaling and promote FHL1 degradation in renal fibrosis.. Pharmacological research. https://doi.org/10.1016/j.phrs.2026.109640
Source records
- pubmed · retrieved 2026-09-25T22:43:33.272Z